Amgen, Teva Antitrust MDL Over Sensipar Going To Del.
The Judicial Panel on Multidistrict Litigation on Wednesday said a Delaware federal court is the best place to centralize four proposed class actions and one individual complaint accusing drug giants Amgen...To view the full article, register now.
Already a subscriber? Click here to view full article